Exome Sequencing and the Management of Neurometabolic Disorders.

ABSTRACT:

Background

Whole-exome sequencing has transformed gene discovery and diagnosis in rare diseases. Translation into disease-modifying treatments is challenging, particularly for intellectual developmental disorder. However, the exception is inborn errors of metabolism, since many of these disorders are responsive to therapy that targets pathophysiological features at the molecular or cellular level.

Methods

To uncover the genetic basis of potentially treatable inborn errors of metabolism, we combined deep clinical phenotyping (the comprehensive characterization of the discrete components of a patient's clinical and biochemical phenotype) with whole-exome sequencing analysis through a semiautomated bioinformatics pipeline in consecutively enrolled patients with intellectual dev

SUBMITTER: Tarailo-Graovac M 

PROVIDER: S-EPMC4983272 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature